title: Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
authors.affiliation: University of California, UCLA, Rheumatology, Division Los Angeles, USA. defurst@mednet.ucla.edu
authors.forename: D E
authors.initials: DE
authors.lastname: Furst
authors.forename: F C
authors.initials: FC
authors.lastname: Breedveld
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
authors.forename: G R
authors.initials: GR
authors.lastname: Burmester
authors.forename: M
authors.initials: M
authors.lastname: Dougados
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: A
authors.initials: A
authors.lastname: Gibofsky
authors.forename: A F
authors.initials: AF
authors.lastname: Kavanaugh
authors.forename: E C
authors.initials: EC
authors.lastname: Keystone
authors.forename: L
authors.initials: L
authors.lastname: Klareskog
authors.forename: A S
authors.initials: AS
authors.lastname: Russell
authors.forename: L B A
authors.initials: LB
authors.lastname: van de Putte
authors.forename: M H
authors.initials: MH
authors.lastname: Weisman
authors.forename: A F
authors.initials: AF
authors.lastname: Kavenaugh
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha